Novel antibacterial targets and compounds revealed by a high-throughput cell wall reporter assay

Journal of Bacteriology
Asha S NayarSarah M McLeod

Abstract

A high-throughput phenotypic screen based on a Citrobacter freundii AmpC reporter expressed in Escherichia coli was executed to discover novel inhibitors of bacterial cell wall synthesis, an attractive, well-validated target for antibiotic intervention. Here we describe the discovery and characterization of sulfonyl piperazine and pyrazole compounds, each with novel mechanisms of action. E. coli mutants resistant to these compounds display no cross-resistance to antibiotics of other classes. Resistance to the sulfonyl piperazine maps to LpxH, which catalyzes the fourth step in the synthesis of lipid A, the outer membrane anchor of lipopolysaccharide (LPS). To our knowledge, this compound is the first reported inhibitor of LpxH. Resistance to the pyrazole compound mapped to mutations in either LolC or LolE, components of the essential LolCDE transporter complex, which is required for trafficking of lipoproteins to the outer membrane. Biochemical experiments with E. coli spheroplasts showed that the pyrazole compound is capable of inhibiting the release of lipoproteins from the inner membrane. Both of these compounds have significant promise as chemical probes to further interrogate the potential of these novel cell wall componen...Continue Reading

References

Nov 1, 1978·The Journal of Antibiotics·M InukaiM Arai
Oct 1, 1972·Canadian Journal of Microbiology·P M Leighton
Jun 11, 1998·Emerging Infectious Diseases·A RattanN Ahmad
Aug 26, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·H Nikaido
Jun 1, 2000·Proceedings of the National Academy of Sciences of the United States of America·K A Datsenko, B L Wanner
Jun 6, 2000·Journal of Biomolecular Screening·J H ZhangK R Oldenburg
May 10, 2002·The Journal of Biological Chemistry·Kristen J BabinskiChristian R H Raetz
May 10, 2002·The Journal of Biological Chemistry·Kristen J BabinskiChristian R H Raetz
May 17, 2002·The Journal of Antibiotics·Dongyu SunDavid M Rothstein
May 17, 2002·The Journal of Antibiotics·Maureen DeCenzoDavid M Rothstein
May 25, 2005·Proceedings of the National Academy of Sciences of the United States of America·Arne RietschJohn J Mekalanos
Dec 13, 2006·Nature Reviews. Drug Discovery·Lynn L Silver
Dec 13, 2006·Nature Reviews. Drug Discovery·David J PayneDavid L Pompliano
Oct 5, 2007·Expert Review of Anti-infective Therapy·Philip D Lister
Jan 4, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Brad SpellbergUNKNOWN Infectious Diseases Society of America
Feb 12, 2008·Journal of Medicinal Chemistry·Rosemarie O'Shea, Heinz E Moser
Feb 12, 2008·Current Protocols in Molecular Biology·Lynn C ThomasonDonald L Court
Apr 19, 2008·The Journal of Infectious Diseases·Louis B Rice
Aug 1, 2009·Journal of Biomolecular Screening·Adam B ShapiroThomas A Keating
Oct 8, 2009·Bioscience, Biotechnology, and Biochemistry·Masaki YasudaShin-ichiro Narita
Oct 10, 2009·Progress in Lipid Research·Xiaoyuan Wang, Peter J Quinn
Nov 10, 2010·Annals of the New York Academy of Sciences·Michael N GwynnDavid J Payne
Jan 15, 2011·Trends in Biotechnology·Timothy D H BuggDavid I Roper
Jan 15, 2011·Clinical Microbiology Reviews·Lynn L Silver
Jun 15, 2011·Annual Review of Microbiology·Suguru Okuda, Hajime Tokuda
Jan 11, 2012·Antimicrobial Agents and Chemotherapy·Yao XiaoDaniel Wall
Jan 20, 2012·Journal of Medicinal Chemistry·Justin I MontgomeryDonn G Wishka
Aug 23, 2012·ACS Chemical Biology·Thomas A KeatingGabriel Martínez-Botella
Oct 26, 2012·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Astrid ZervosenAndré Luxen
Nov 21, 2012·Annals of the New York Academy of Sciences·Jarrod W JohnsonShahriar Mobashery
Jan 22, 2013·The Lancet Infectious Diseases·John H RexJennifer Jackson
Mar 19, 2013·Bioorganic & Medicinal Chemistry Letters·Michael R HaleWei Yang
Jun 5, 2013·Frontiers in Microbiology·Ximin Zeng, Jun Lin
Sep 18, 2013·Antimicrobial Agents and Chemotherapy·Boudewijn L M de JongeJason Thresher
Sep 21, 2013·Proceedings of the National Academy of Sciences of the United States of America·Poochit NonejuieJoe Pogliano
Dec 18, 2013·Journal of the American Chemical Society·Tania J LupoliSuzanne Walker
Sep 24, 2014·Antimicrobial Agents and Chemotherapy·Jun FanScott D Mills

❮ Previous
Next ❯

Citations

Sep 6, 2015·International Journal of Antimicrobial Agents·Veronica L CaveraMichael L Chikindas
Jul 4, 2015·Nature Reviews. Drug Discovery·Ruben TommasiAlita A Miller
May 5, 2016·Biomedit︠s︡inskai︠a︡ khimii︠a︡·P V SergievO A Dontsova
Jul 1, 2016·Annual Review of Microbiology·Jeremy C HendersonM Stephen Trent
Jan 18, 2018·Antimicrobial Agents and Chemotherapy·Nicholas N NickersonMireille Nishiyama
Jun 26, 2018·Angewandte Chemie·Markus LakemeyerStephan A Sieber
Jan 27, 2018·Nature Communications·Heather O BohlHideki Aihara
Nov 26, 2019·Annals of the New York Academy of Sciences·Craig R MacNairEric D Brown
Jan 30, 2020·Current Drug Targets·Usha K RoutGaurav R Dwivedi
Oct 3, 2018·Frontiers in Cellular and Infection Microbiology·Zhendong LiGuoqiang Zhu
Mar 23, 2019·Scientific Reports·Sannah ZoffmannMarco Prunotto
Apr 19, 2017·Proceedings of the National Academy of Sciences of the United States of America·Marcin Grabowicz, Thomas J Silhavy
Jul 18, 2018·Proceedings of the National Academy of Sciences of the United States of America·Elise KaplanVassilis Koronakis
May 31, 2019·Nature Reviews. Microbiology·Brent W Simpson, M Stephen Trent
Jun 13, 2018·Frontiers in Microbiology·Nicholas P GreeneVassilis Koronakis
Feb 12, 2020·Proceedings of the National Academy of Sciences of the United States of America·Jae ChoPei Zhou
Jun 17, 2020·Future Medicinal Chemistry·George A Naclerio, Herman O Sintim
Sep 27, 2020·Molecular Microbiology·Simon LegoodNienke Buddelmeijer
Oct 7, 2019·Bioorganic Chemistry·Hailey A J Hibbard, Melissa M Reynolds
Jul 15, 2020·Bioorganic Chemistry·Seung-Hwa KwakJiyong Hong
Sep 5, 2020·European Journal of Medicinal Chemistry·Preeti RanaSrinivas Nanduri
Mar 31, 2021·Nature Structural & Molecular Biology·Xiaodi TangHaohao Dong
Aug 5, 2021·Nature Communications·Stuti SharmaMaofu Liao
Oct 31, 2019·Journal of Chemical Information and Modeling·Pavel V PogodinVladimir V Poroikov
Aug 29, 2021·Pharmacology & Therapeutics·Pilar Garcia-VelloAntonio Molinaro

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.